News and Events

IntraOp Medical Corporation today announced a partnership with Heidelberg University Hospital, one of Europe’s largest and most esteemed medical centers, to advance clinical use of FLASH IORT for treating pancreatic cancer.

SALK Physicians Leveraged Advanced IORT Technology to Offer Safe and Effective Cancer Treatment During the COVID-19 Pandemic IntraOp Medical Corporation announced today that University Hospital Salzburg (SALK) Austria has treated its 150th patient since installing IntraOp’s third generation Mobetron system in January 2021.  With extended gantry movement, automatic docking and streamlined treatment planning, IORT is … Continued

First patients enrolled in the Impulse Trial: A phase I dose-escalation study of high dose rate radiotherapy with electrons in patients with skin metastases from melanoma.

At Ohio State University, President Biden Introduced to the Future Potential of FLASH with Electrons Last week, U.S. President Joe Biden visited the Ohio State University James Comprehensive Cancer Center (OSUCCC) to discuss the latest innovations in cancer research. President Biden has committed his administration’s support to “end cancer as we know it” and is … Continued

IntraOp Medical Corporation and the University of Verona in Italy announced today the enrollment of the first patient in the PancFORT Trial: A phase II study of primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.